Last Update 03 Nov 25
Analysts have raised their price targets for TPG, with recent updates moving estimates from $58 to as high as $69 per share. Strong fundraising activity and improving capital market conditions support a positive outlook for the firm.
Analyst Commentary
Analysts have provided a range of perspectives on TPG, highlighting both its strong recent performance and areas that warrant caution. Their commentary offers insights into the firm's growth prospects, market positioning, and potential risks facing investors.
Bullish Takeaways
- Bullish analysts have continued to raise their price targets for TPG, citing robust fundraising activity and consistent execution as reasons for their optimism.
- TPG is projected to deliver the strongest quarter among its asset manager peers. This reflects improved investing activity and favorable capital market conditions.
- The firm's expanding product suite and progress in wealth management are viewed as key drivers supporting its long-term growth trajectory.
- Positive commentary also highlights that TPG's brand strength positions it well for further gains as it continues early moves into new segments.
Bearish Takeaways
- Bearish analysts caution that near-term credit concerns may impact market valuations for TPG. This could temper upside potential in the short run.
- Competition and execution risks, particularly as the company expands into new business lines, could challenge the consistency of earnings growth.
- There is some caution that recent market rebounds may not be sustainable. Macroeconomic factors continue to pose ongoing uncertainty for asset managers broadly.
What's in the News
- Blackstone and TPG are in advanced talks to acquire medical device maker Hologic, with the deal potentially valued above $17 billion including debt. Negotiations continue, and an announcement could be imminent, though the agreement is not final (Bloomberg).
- Blackstone and TPG have revived and progressed discussions with Hologic's board in recent weeks, conducting due diligence on a possible takeover. Hologic shares rose 8% after the news (Bloomberg).
- This prospective acquisition of Hologic by TPG and Blackstone would mark one of the largest take-private deals of the year, with debt financing reportedly secured. Earlier bids were rejected, and the final terms are still being negotiated (Financial Times).
Valuation Changes
- Fair Value: Remains unchanged at $65.92 per share. This reflects stability in analysts' intrinsic valuation for TPG.
- Discount Rate: Decreased slightly from 8.31% to 8.29%. This indicates a minor reduction in perceived risk or required return.
- Revenue Growth: Unchanged at -16.11%. This signals that near-term expectations for sales trajectories remain consistent.
- Net Profit Margin: Remains stable at 35.67%. This suggests ongoing expectations for profitability levels.
- Future P/E: Edged down marginally from 18.42x to 18.41x. This indicates a minimal decline in anticipated earnings valuation multiples.
Key Takeaways
- Expansion into private wealth, insurance, and tailored partnerships is driving revenue stability, higher fee margins, and improved management fee growth and retention.
- Strategic acquisitions and a thematic focus on high-growth sectors are strengthening earnings, platform scale, operating leverage, and long-term returns.
- TPG faces constrained fundraising, earnings pressure, execution risks from expansion, tougher exits in volatile markets, and higher compliance burdens amid growing scrutiny of private equity.
Catalysts
About TPG- Operates as an alternative asset manager in the United States and internationally.
- Rapid fundraising growth-particularly $11.3 billion raised this quarter (up nearly 80% YoY) and strong, above-target commitments for new funds-demonstrates TPG's ability to capture increasing institutional and global capital allocations to alternatives, which supports significant management fee revenue expansion and higher overall revenue visibility.
- Expansion into private wealth/retail (e.g., T-POP, TCAP) and insurance channels is driving a diversified, stable fee stream and increasing management fee margins, positioning TPG to benefit from the long-term industry trend of rising wealth and institutional demand for alternatives, which enhances topline growth and net margin stability.
- Strategic investments and acquisitions-such as the Peppertree acquisition (immediately accretive to fee-related earnings) and new fund launches-are increasing platform scale and operating leverage, translating into improved net margins and supporting long-term earnings growth as the firm captures a larger share of the expanding private markets opportunity set.
- Thematic investment focus in high-growth areas (sustainability, digital infrastructure, healthcare, AI) is enabling TPG to capitalize on long-term, secular shifts toward these sectors, driving outperformance in investment returns and supporting growth in carried interest and incentive income, positively impacting earnings.
- Increased cross-platform strategic partnerships with large institutional investors and tailored product innovation are lengthening capital duration, improving fundraising efficiency and recurring revenue, and supporting higher AUM retention-further strengthening forward net income and margin resilience.
TPG Future Earnings and Revenue Growth
Assumptions
How have these above catalysts been quantified?- Analysts are assuming TPG's revenue will decrease by 16.5% annually over the next 3 years.
- Analysts assume that profit margins will increase from 0.5% today to 36.5% in 3 years time.
- Analysts expect earnings to reach $827.7 million (and earnings per share of $3.8) by about September 2028, up from $20.2 million today.
- In order for the above numbers to justify the analysts price target, the company would need to trade at a PE ratio of 46.0x on those 2028 earnings, down from 430.7x today. This future PE is greater than the current PE for the US Capital Markets industry at 26.7x.
- Analysts expect the number of shares outstanding to grow by 7.0% per year for the next 3 years.
- To value all of this in today's terms, we will use a discount rate of 8.3%, as per the Simply Wall St company report.
TPG Future Earnings Per Share Growth
Risks
What could happen that would invalidate this narrative?- Increased allocations to private equity by large institutional investors are impacting many firms, but industry surveys indicate that a significant proportion of LPs now feel overweight in alternatives-suggesting that future fundraising growth could be constrained, reducing TPG's long-term fee revenue and AUM growth prospects.
- Persistent headwinds in private equity fundraising, with clients remaining cautious and selective, indicate that even large players like TPG may face episodic slowdowns in capital flows, directly impacting net management fees and earnings visibility.
- The IPO of TPG has coincided with the firm aggressively scaling new product lines (e.g., T-POP, credit platforms, international expansion), which introduces execution and integration risks; unsuccessful product launches or acquisitions could dilute margins and depress realized earnings over time.
- Broader private equity industry trends point to challenges in exiting portfolio companies amid volatile capital markets and muted IPO/M&A activity; this could result in lower realization gains and carried interest for TPG during downturns, directly affecting net income and distributable earnings.
- Ongoing regulatory scrutiny, potential new taxes, and public criticism of private equity practices (especially related to income inequality and insurance strategies) could increase compliance costs, depress sentiment among investors, and constrain TPG's ability to raise or deploy capital efficiently, ultimately reducing profitability and net margins.
Valuation
How have all the factors above been brought together to estimate a fair value?- The analysts have a consensus price target of $64.818 for TPG based on their expectations of its future earnings growth, profit margins and other risk factors. However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $70.0, and the most bearish reporting a price target of just $58.0.
- In order for you to agree with the analyst's consensus, you'd need to believe that by 2028, revenues will be $2.3 billion, earnings will come to $827.7 million, and it would be trading on a PE ratio of 46.0x, assuming you use a discount rate of 8.3%.
- Given the current share price of $58.95, the analyst price target of $64.82 is 9.1% higher. The relatively low difference between the current share price and the analyst consensus price target indicates that they believe on average, the company is fairly priced.
- We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.
How well do narratives help inform your perspective?
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.



